Latest news with #RSU
Yahoo
03-07-2025
- Business
- Yahoo
Aduro Clean Technologies Announces Grant of Stock Options and RSUs
LONDON, Ontario, July 03, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. ('Aduro' or the 'Company') (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, announces today that it has granted (the 'Option Grant') an aggregate of 743,500 stock options (each, an 'Option') to purchase up to 743,500 common shares of the Company to certain directors, officers, employees and consultants of the Company. The Options are exercisable for a period of 5 years from the date of Grant at a price of $13.50 per common share. The Options will vest on a monthly basis over a period of two years from the date of the Option Grant. In addition, the Company granted (the 'RSU Grant') 100,000 restricted share units of the Company (each, an 'RSU') to a consultant of the Company. Each RSU represents the right to receive, once vested, one common share in the capital of the Company. The RSUs will vest in three tranches, with the 35,000 RSUs vesting immediately upon the date of grant, 35,000 RSUs vesting on the date which is 6 months following the date of grant, and 30,000 RSUs vesting on the date which is 12 months following the date of grant. All 743,500 of the Options, 100,000 of the RSUs, and the common shares underlying such Options and RSUs are subject to a hold period of four months and one day from the date of issuance. None of the securities acquired in the Option Grant or the RSU Grant will be registered under the United States Securities Act of 1933, as amended (the '1933 Act'), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This news release shall not constitute an offer to sell or solicitation of an offer to buy nor shall there be any sale of the securities in any state where such offer, solicitation, or sale would be unlawful. About Aduro Clean Technologies Aduro Clean Technologies is a developer of patented water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil; and transform renewable oils into higher-value fuels or renewable chemicals. The Company's Hydrochemolytic™ Technology relies on water as a critical agent in a chemistry platform that operates at relatively low temperatures and cost, a game-changing approach that converts low-value feedstocks into resources for the 21st century. For further information, please contact: Abe Dyck, Head of Business Development and Investor Relationsir@ 226 784 8889 KCSA Strategic CommunicationsJack Perkins, Senior Vice Presidentaduro@ news release contains forward-looking statements. All statements, other than statements of historical fact, that address activities, events, or developments that the Company believes, expects, or anticipates will or may occur in the future are forward-looking statements. These include, but are not limited to, statements regarding the anticipated benefits of the Option Grant and RSU Grant, including the Company's ability to attract and retain qualified personnel and consultants, and the potential contributions of such individuals to the Company's business objectives. Forward-looking statements reflect management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause actual outcomes to differ materially from those discussed in the forward-looking statements. Although the Company believes that the assumptions underlying these statements are reasonable, forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated. Important factors that could cause actual results to differ materially include, but are not limited to, changes in market conditions, the Company's ability to execute its business strategy, the performance and retention of key personnel and consultants, and other risks detailed from time to time in the Company's public disclosure documents. The Company disclaims any intent or obligation to update or revise any forward-looking statements, except as required by applicable law.A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Forbes
01-07-2025
- Business
- Forbes
Restricted Stock Units: 6 Tax And Financial-Planning Strategies
Restricted stock units (RSUs) are a deceptively complex form of employee equity compensation. They ... More require a cohesive tax and financial plan. Beware. When you receive a grant of restricted stock units (RSUs), do not make the mistake of thinking the tax and financial planning is simple. You recognize income and owe taxes on the shares' value when the stock is delivered at vesting—whether you're ready or not! Then, when you sell the shares, how long you kept them separately affects your capital gain or loss for taxes. In a recent webinar that I moderated, three elite financial advisors who have extensive experience in planning with RSUs, stock options, and ESPPs discussed the various strategies and topics that they review with their clients. This article presents six of their insights. 1. RSU Vesting: Tax Withholding For webinar panelist Travis Gatzemeier, the founder of Kinetix Financial Planning in the Dallas–Fort Worth area of Texas, tax awareness and planning are the starting points for clients with RSUs. Tax withholding is often the very first topic he discusses. 'The biggest thing I see with RSUs is under-withholding on taxes at vesting,' he stated. Companies withhold taxes on the income recognized at RSU vesting, but often the flat federal withholding rate used for this type of income is not enough to cover all the taxes you owe. The required federal rate is 22% up to $1 million in a calendar year and 37% for amounts in excess of that, though some companies now allow a rate election. 'Newer clients especially will come in wondering why they have such a big tax bill.' 'The primary thing that I help my RSU clients with is tax withholding,' concurred webinar panelist Valerie Gospodarek, the owner of VG Financial Consulting in the San Francisco Bay area in California. 'I can't tell you how many people are surprised that they have a large tax bill when they're doing their tax returns for the year. I help make sure they've held enough throughout the year. It does get a little challenging, especially if the stock price has been volatile.' The higher the RSU income, the more likely it is that taxes on the income will be under-withheld at vesting, observed webinar panelist CJ Stermetz, the founder of the firm Equity For The Win in San Jose, California. If shares cannot be sold to cover the additional taxes, other ways to do so will have to be planned, he said. One common method is quarterly estimated taxes. However, that's tricky if the prior year's income, on which estimated taxes are based, is very different to this year's income. The best solution to avoid IRS and state underpayment penalties, Stermetz recommends, 'is to be sure we're running quarterly tax projections or talking with a CPA to keep on track with the safe harbor for federal taxes during the year.' 2. Questions For RSU Planning RSUs, with their fixed vesting schedules, often seem simple relative to the more complex planning around stock option exercise strategies. However, Stermetz warned that this appearance can be deceptive. 'There's a lot of organization and a lot of details that can go wrong,' Stermetz warned. That is why it's important for him to understand clients' situations long before the specifics of tax planning come into play. These include any intention they may have to move states during the vesting period, which then raises separate mobility tax issues; and dates for ESPP purchases, stock option exercises, and RSU vestings that can cause wash sale issues for company stock sold at a loss. He noted several questions that he talks through with clients: Stermetz revealed that the issue of concentration in company stock is sometimes particularly difficult, not least because the client's spouse may not even be aware of the concentration level and the related financial risk. 'I see it all the time that a client is busy working crazy hours at a tech company and has amassed a ton of wealth, but the spouse has no idea that their entire livelihood depends on the performance of this one company's stock,' he said. 3. Reducing Income In Years RSUs Vest Both Stermetz and Gatzemeier explained how you can plan around the RSU income to reduce your overall tax hit beyond just harvesting capital losses. They discussed many ways to do this to lower your other taxable income in a vesting year. Ideas to consider include: 4. Decisions At Vesting: Hold Or Sell? Once you own the shares, you must decide whether to hold them or sell them. Gospodarek said she routinely advises her clients to sell RSU shares as soon as they receive them at vesting, 'before the price has a chance to fluctuate a lot.' This is particularly a concern, she asserted, for clients who already have a lot of wealth concentrated in holdings of company stock. 'There's just no need to take on more risk with that stock.' Gatzemeier said that he guides his clients through the decision about how many shares to hold and how many to sell after RSU vesting—but the decision that clients reach is often the same. 'A lot of times for my clients it is selling immediately to use those proceeds to deploy toward other areas of their financial lives,' he said. 5. Trading Windows Impact Selling Plans A selling plan for RSUs usually depends heavily on company trading windows, when employees are allowed to sell shares of company stock. That is a big piece of the RSU organization puzzle, said Stermetz. 'When we say 'sell your RSUs at vesting' we don't necessarily mean sell literally when they vest,' clarified Stermetz, building on what Gatzemeier and Gospodarek noted about hold/sell decisions at RSU vesting. 'We mean 'sell when you are able to sell them' according to the company trading windows,' along with the others rules to prevent insider trading and any Rule 10b5-1 trading plan you may have. It's important for clients to know that, for example, shares which vest on January 1 may not be sellable until February 1, he said. 'Typically trading windows will happen after an earnings call, and the window is usually four to six weeks,' observed Stermetz. 'You can't necessarily know all the dates exactly for a whole year, but you can estimate according to what's been done in the past.' Stermetz then takes the client's RSU vesting schedule for the year and compares it to the set of company trading windows for stock sales that the client is likely to have. 6. RSU Taxes As A Financial-Planning Motivator While advisors generally tell clients that taxes should not be the primary driver of investment decisions, Stermetz finds that the exigency of paying taxes can make it easier to advise a client to sell company stock from an overly concentrated position. 'Sometimes for clients who are afraid to sell a concentrated position, having a tax rationale for why they should sell is a really good incentive to sell that stock,' he revealed. 'If they're under-withheld and need to sell some of that stock to pay their tax bill, they will be willing to do it.' That, in turn, can help the client stick to a plan of regular sales of shares acquired from RSU vestings. Gatzemeier echoed the importance of anticipation about taxes and concentrated positions with RSUs, especially in a volatile stock market. 'You really can't do much financial planning until you have done a tax-awareness exercise so you know what's left.' If you eventually realize you have to sell stock to pay extra taxes on RSU income but by then the stock price has declined significantly, you're in a lurch. 'It's a bad experience for a client if the taxes are not planned out well ahead of time.' Further Resources On Restricted Stock Units The webinar in which these advisors spoke is available on demand at the myStockOptions Webinar Channel. More advisor views on RSU planning are available through articles from financial planners in the section Restricted Stock Units at which also has RSU planning tools and courses.


Hans India
30-06-2025
- Entertainment
- Hans India
‘Veede Mana Vaarasudu'pre-release event creates buzz
A film carrying a socially relevant message, Veede Mana Vaarasudu held its grand pre-release event at Prasad Labs, Hyderabad. Headlined by multi-talented Ramesh Uppu (RSU), who serves as the film's writer, director, producer, and lead actor, the movie stars Lavanya Reddy and Sarvani Mohan as the female leads. Prominent figures from the film and political circles attended the event, praising Ramesh Uppu's versatility and comparing him to the legendary Dasari Narayana Rao. Actor 30 Years Prithvi, directors VN Aditya and Samudra, MLA Mal Reddy Rangareddy, and Congress leader Surender Reddy were among the key guests who extended their best wishes. MLA Mal Reddy Rangareddy recalled Ramesh Uppu's earlier musical contributions and lauded his passion and talent. VN Aditya admired the film's trailer and action sequences, while Surender Reddy urged widespread support, saying, 'Every drop makes an ocean.' Samudra expressed strong confidence in the film's success. Police officer RamaavathTeja light-heartedly remarked that even the law was on the movie's side, while actor Krishnasai praised RSU's multi-departmental prowess. Set for release on July 18 across Telugu states, Veede Mana Vaarasudu highlights the struggles of farmers through an emotionally rich narrative. The lead actresses, Lavanya Reddy and Sarvani Mohan, expressed pride in being part of a meaningful, rural-rooted project, confident that the film will resonate widely and emerge a success.


Hans India
26-06-2025
- Entertainment
- Hans India
‘Veede Mana Vaarasudu' set for release on July 18
Veede Mana Vaarasudu, a socially relevant and emotionally charged drama rooted in the struggles of farmers, is all set to hit theatres across the Telugu states on July 18. Written, directed, produced, and headlined by Ramesh Uppu (RSU), the film promises a heartfelt cinematic experience with strong social messaging. In addition to playing the lead role, RSU has taken on multiple creative responsibilities—writing the screenplay, penning dialogues and lyrics, and even lending his voice to the film's songs. The film is produced under the R.S. Arts banner and is presented by U Ramadevi. Starring Lavanya Reddy and Sarvani Mohan alongside RSU, the film also features supporting performances by Sammetha Gandhi, Vijay Rangaraju, Anand Bharathi, Guduru Kishore, and Shilpa (Vizag). The film recently completed its censor formalities and received positive feedback from board members, who appreciated its depiction of family values, the challenges faced by farmers, and its hard-hitting commentary on youth drug abuse. Speaking about the film, RSU shared, 'Veede Mana Vaarasudu carries a message that society needs today. The emotional layers in the story are sure to strike a chord with viewers. Encouragement from the censor board and early viewers has reaffirmed our faith in the film. We hope the audience supports this honest effort and joins us in theatres.' Promotional activities have already begun, generating strong interest. A pre-release event is planned for June 29, while early premiere shows for select dignitaries have garnered praise, further adding to the film's buzz. With its powerful narrative and socially conscious themes, Veede Mana Vaarasudu aims to touch hearts and spark conversations.


Business Wire
12-06-2025
- Business
- Business Wire
NEUPATH HEALTH ANNOUNCES VOTING RESULTS FROM THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), ('NeuPath' or the 'Company'), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and Special Meeting of Shareholders (the 'Meeting') held on June 11, 2025 and the grant of stock options ('Options') and restricted share units ('RSUs'). All figures are in Canadian dollars, unless otherwise noted. The results of the director elections were as follows: The shareholders of the Company also voted: (i) to reappoint Ernst & Young LLP, Chartered Professional Accountants, Licensed Public Accountants, as auditors of the Company for the ensuing year, (ii) to approve the Company's amended and restated stock option plan in the form attached as Schedule 'A' to the management information circular dated April 22, 2025 prepared in connection with the Meeting (the 'Stock Option Plan'), and (iii) to approve the Company's amended and restated restricted share unit plan in the form attached as Schedule 'B' to the management information circular dated April 22, 2025 prepared in connection with the Meeting (the 'RSU Plan'). Amendments to the RSU Plan At the Meeting, the Company proposed the adoption of the RSU Plan which was amended to increase the maximum number of common shares of the Company ('Common Shares') issuable thereunder from 3,000,000 Common Shares to 5,000,000 Common Shares. At the Meeting, 99.38% shareholder votes cast were in favour of adopting the RSU Plan. Issuance of Stock Options and Restricted Share Units On June 12, 2025, NeuPath granted an aggregate of 150,000 Options to non-executive directors of the Company at an exercise price of $0.26 per share, with an expiry date of June 12, 2032. The Options are subject to time-based vesting and will fully vest on June 12, 2026. The terms of the Options granted are in accordance with the Stock Option Plan. In addition, on June 12, 2025, the Company granted an aggregate of 60,000 RSUs to the same non-executive directors of the Company. The RSUs are subject to time-based vesting in accordance with the policies of the TSX Venture Exchange. RSUs granted will fully vest on June 12, 2026. The terms of the RSUs granted are in accordance with the RSU Plan. About NeuPath NeuPath operates a network of healthcare clinics and related businesses focused on improved access to care and outcomes for patients by leveraging best-in-class treatments and delivering patient-centered multidisciplinary care. We operate a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. In addition, NeuPath provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical and biotechnology companies. NeuPath is focused on enabling each individual to live their best life. For additional information, please visit